Shell Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.52M Sell
33,666
-52,672
-61% -$2.46M 0.15% 152
2025
Q2
$4M Buy
86,338
+23,772
+38% +$1.17M 0.14% 148
2025
Q1
$3.82M Sell
62,566
-1,836
-3% -$107K 0.18% 109
2024
Q4
$3.64M Sell
64,402
-4,486
-7% -$251K 0.16% 121
2024
Q3
$3.56M Buy
+68,888
New +$3.23M 0.16% 125
2024
Q1
$2.92M Sell
70,314
-3,612
-5% -$184K 0.13% 142
2023
Q4
$3.79M Sell
73,926
-22,630
-23% -$1.19M 0.18% 116
2023
Q3
$5.6M Sell
96,556
-1,623
-2% -$99.4K 0.23% 80
2023
Q2
$6.28M Sell
98,179
-39,230
-29% -$2.63M 0.25% 71
2023
Q1
$9.52M Sell
137,409
-7,935
-5% -$560K 0.4% 49
2022
Q4
$10.5M Buy
145,344
+4,910
+3% +$370K 0.46% 46
2022
Q3
$9.98M Sell
140,434
-35,872
-20% -$2.6M 0.39% 48
2022
Q2
$13.6M Sell
176,306
-6,410
-4% -$488K 0.4% 49
2022
Q1
$13.3M Sell
182,716
-39,479
-18% -$2.65M 0.32% 61
2021
Q4
$13.9M Buy
222,195
+14,841
+7% +$871K 0.28% 65
2021
Q3
$12.3M Sell
207,354
-51,785
-20% -$3.41M 0.28% 76
2021
Q2
$17.3M Sell
259,139
-24,435
-9% -$1.59M 0.34% 58
2021
Q1
$17.9M Buy
283,574
+95,322
+51% +$5.93M 0.36% 59
2020
Q4
$11.7M Sell
188,252
-16,035
-8% -$986K 0.24% 94
2020
Q3
$12.3M Buy
204,287
+32,331
+19% +$1.95M 0.29% 87
2020
Q2
$10.1M Sell
171,956
-20,146
-10% -$1.2M 0.25% 101
2020
Q1
$10.7M Buy
192,102
+9,770
+5% +$597K 0.3% 69
2019
Q4
$11.7M Buy
182,332
+36,078
+25% +$2.07M 0.25% 90
2019
Q3
$7.42M Buy
146,254
+14,901
+11% +$700K 0.17% 151
2019
Q2
$5.96M Buy
131,353
+1,127
+0.9% +$52.5K 0.13% 194
2019
Q1
$6.21M Hold
130,226
0.14% 194
2018
Q4
$6.77M Sell
130,226
-21,329
-14% -$1.15M 0.17% 158
2018
Q3
$9.41M Sell
151,555
-9,461
-6% -$561K 0.19% 138
2018
Q2
$8.91M Sell
161,016
-48,417
-23% -$2.61M 0.18% 149
2018
Q1
$13.2M Buy
209,433
+6,183
+3% +$398K 0.26% 99
2017
Q4
$12.5M Buy
203,250
+26,458
+15% +$1.65M 0.25% 105
2017
Q3
$11.3M Sell
176,792
-29,503
-14% -$1.72M 0.25% 118
2017
Q2
$11.5M Sell
206,295
-45,161
-18% -$2.46M 0.25% 114
2017
Q1
$13.7M Buy
251,456
+22,977
+10% +$1.26M 0.3% 88
2016
Q4
$13.4M Sell
228,479
-32,361
-12% -$1.77M 0.31% 83
2016
Q3
$14.1M Sell
260,840
-32,235
-11% -$2.07M 0.29% 89
2016
Q2
$21.6M Buy
293,075
+37,917
+15% +$2.68M 0.5% 49
2016
Q1
$16.3M Sell
255,158
-32,857
-11% -$2.07M 0.39% 64
2015
Q4
$19.8M Sell
288,015
-196,210
-41% -$13M 0.47% 43
2015
Q3
$24.8M Buy
484,225
+110,229
+29% +$6.99M 0.39% 48
2015
Q2
$24.9M Sell
373,996
-59,625
-14% -$3.93M 0.5% 41
2015
Q1
$28M Sell
433,621
-14,789
-3% -$926K 0.49% 40
2014
Q4
$26.5M Sell
448,410
-35,815
-7% -$2.02M 0.42% 50
2014
Q3
$24.8M Sell
484,225
-5,757
-1% -$288K 0.38% 48
2014
Q2
$23.8M Buy
489,982
+19,348
+4% +$953K 0.37% 53
2014
Q1
$24.4M Buy
470,634
+7,348
+2% +$391K 0.41% 38
2013
Q4
$24.6M Sell
463,286
-277,649
-37% -$14.1M 0.42% 35
2013
Q3
$34.3M Sell
740,935
-8,611
-1% -$378K 0.63% 23
2013
Q2
$33.5M Buy
+749,546
New +$32.5M 0.64% 24

Other funds holding BMY

Shell Asset Management's BMY Position: Q3 2025 in Review

Shell Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 61% in Q3 2025, selling an estimated $2.46M and leaving 33,666 shares worth $1.52M. The position accounts for 0.15% of the portfolio, ranked #152.

Shell Asset Management first reported a position in BMY in Q2 2013 and has held it in 49 quarters since. The position peaked at $34.3M in Q3 2013. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Shell Asset Management held 33,666 shares of Bristol-Myers Squibb worth $1.52M as of Q3 2025.
  • Shell Asset Management sold 52,672 Bristol-Myers Squibb shares in Q3 2025, an estimated $2.46M.
  • Bristol-Myers Squibb made up 0.15% of Shell Asset Management's portfolio in Q3 2025, its #152 holding.
  • Shell Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 49 quarters since.
  • Shell Asset Management's Bristol-Myers Squibb position peaked at $34.3M in Q3 2013.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.